siRNA, Anti-Human CYP2A7, LNA(CAT#: SIRGT09053WQ-LNA)

The product SIRGT09053WQ-LNA is a type of small interfering RNA (siRNA) that targets CYP2A7 gene and regulates the expression of gene. The siRNA interferes with the expression of CYP2A7 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_000764.2; NM_030589.2
Alternative Names CPA7; CPAD; CYP2A; CYPIIA7; P450-IIA4
Related Diseases Metabolism
Purification HPLC
Target Gene
Gene ID 1549
Uniprot ID P20853

Related Products

Advertisement